NCT01464216View on ClinicalTrials.gov

MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness

Active, not recruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2030

Conditions
Prostatic NeoplasmsGenital Neoplasms, MaleProstatic Diseases
Trial Locations (1)

0310

Oslo University Hospital, Oslo

All Listed Sponsors
collaborator

Radboud University Medical Center

OTHER

lead

Oslo University Hospital

OTHER

NCT01464216 - MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness | Biotech Hunter | Biotech Hunter